Published by The Medical Letter, Inc. • 1000 Main Street, New Rochelle, N.Y. 10801 • A Nonprofit Publication

   options

 
Select a year:   
TABLE OF CONTENTS
2004 issues - volume 46 • The Medical Letter Accessing & Pricing  
show summaries 
December 6, 2004 (Issue 1197)  
Dangerous Drugs  p.97  
Treatment of Menopausal Vasomotor Symptoms  p.98  
Drugs for Percutaneous Coronary Interventions  p.100  
November 22, 2004 (Issue 1196)   top
Safety of Aggressive Statin Therapy  p.93  
L-Carnitine  p.95  
November 8, 2004 (Issue 1195)  
Tablet Splitting  p.89  
COX-2 Alternatives and GI Protection  p.91  
Systemic Reactions to Imiquimod (Aldara)  p.92  
October 25, 2004 (Issue 1194)   top
Antiviral Drugs for Prophylaxis and Treatment of Influenza  p.85  
What About Celebrex?  p.87  
October 11, 2004 (Issue 1193)  
Duloxetine (Cymbalta): A New SNRI for Depression  p.81  
Influenza Vaccine 2004-2005  p.83  
Generic Levothyroxine - Addendum  p.80  
September 20, 2004 (Issue 1192)   top
Generic Levothyroxine  p.77  
Gemifloxacin (Factive)  p.78  
Cinacalcet (Sensipar)  p.80  
September 13, 2004 (Issue 1191)  
Vytorin: A Combination of Ezetimibe and Simvastatin  p.73  
Rifaximin (Xifaxan) for Travelers' Diarrhea  p.74  
Botulinum Toxin (Botox) for Axillary Hyperhydrosis  p.76  
August 30, 2004 (Issue 1190)   top
Menostar - A Low-Dose Estrogen Patch for Osteoporosis  p.69  
Tinidazole (Tindamax) - A New Anti-Protozoal Drug  p.70  
August 16, 2004 (Issue 1189)  
Atomoxetine (Strattera) Revisited  p.65  
Telithromycin (Ketek) for Respiratory Infections  p.66  
Telithromycin (Ketek) for Respiratory Infections--Correction  p.66  
Drugs for Parasitic Infections  p.1  
August 2, 2004 (Issue 1188)   top
Do NSAIDs Interfere with the Cardioprotective Effects of Aspirin?  p.61  
Methamphetamine Abuse  p.62  
Trospium (Sanctura): Another Anticholinergic for Overactive Bladder  p.63  
July 19, 2004 (Issue 1187)  
Performance-Enhancing Drugs  p.57  
Catheter Ablation for Atrial Fibrillation  p.59  
July 5, 2004 (Issue 1186)   top
Initial Therapy of Hypertension  p.53  
Amlodipine/Atorvastatin (Caduet)  p.56  
June 21, 2004 (Issue 1185)  
Conductive Keratoplasty (CK) for Presbyopia  p.49  
Topical Sertaconazole (Ertaczo) -- Another Azole for Tinea Pedis  p.50  
June 7, 2004 (Issue 1184)   top
Prevention and Treatment of Sunburn  p.45  
Two New Drugs for Colon Cancer  p.46  
Growth Hormone for Normal Short Children - Correction  p.46  
May 24, 2004 (Issue 1183)  
Tiotropium (Spiriva) for COPD  p.41  
Imiquimod (Aldara) for Actinic Keratoses  p.42  
Cosmetic Phalloplasty  p.44  
May 10, 2004 (Issue 1182)   top
Cholesterol Rethink for High-Risk Patients  p.37  
Stalevo for Parkinson's Disease  p.39  
April 26, 2004 (Issue 1181)  
Novoseven for Non-Hemophilia Hemostasis  p.33  
New Indications for Modafinil (Provigil)  p.34  
Epinastine Ophthalmic Solution (Elestat)  p.35  
April 12, 2004 (Issue 1180)   top
Gabapentin (Neurontin) for Chronic Pain  p.29  
Pemetrexed (Alimta) for Mesothelioma  p.31  
March 29, 2004 (Issue 1179)  
Ophthalmic Moxifloxacin (Vigamox) and Gatifloxacin (Zymar)  p.25  
Palonosetron (Aloxi) for Prevention of Nausea and Vomiting Due to Cancer Chemotherapy  p.27  
March 15, 2004 (Issue 1178)   top
Private Cord Blood Banks  p.21  
Abarelix (Plenaxis) for Advanced Prostate Cancer  p.22  
Olanzapine/Fluoxetine (Symbyax) for Bipolar Depression  p.23  
March 1, 2004 (Issue 1177)  
Folic Acid Supplementation to Prevent Neural Tube Defects  p.17  
Sildenafil for Pulmonary Hypertension  p.18  
An Injectable Hyaluronic Acid (Restylane) for Wrinkles  p.17  
February 16, 2004 (Issue 1176)   top
Drugs for Intermittent Claudication  p.13  
Is Effexor More Effective than an SSRI?  p.15  
FluMist: An Intranasal Live Influenza Vaccine - Addendum  p.16  
February 2, 2004 (Issue 1175)  
Seasonale  p.9  
Emergency Contraception OTC  p.10  
Daptomycin (Cubicin) for Skin and Soft Tissue Infections  p.11  
January 19, 2004 (Issue 1174)   top
Lasik and Its Alternatives: An Update  p.5  
Zolmitriptan (Zomig) Nasal Spray for Migraine  p.7  
Efalizumab (Raptiva) for Treatment of Psoriasis - Two Corrections  p.7  
January 5, 2004 (Issue 1173)  
Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia  p.1  
Drug Interactions with Grapefruit Juice  p.2  
Addendum: Alfuzosin (Uroxatral) -- Another Alpha1-blocker for Benign Prostatic Hyperplasia  p.4  
Article Accessing and Pricing
  FREE to everyone
  FREE to subscribers
Issue is available online to The Medical Letter subscribers signed up for online privileges.
 Issue is free to institutional users.
  $12.00
Non-subscribers may order copies of this issue of The Medical Letter and receive by postal mail or electronic download.
  $10.00
Non-subscribers may purchase online by credit card on our secure server and download this The Medical Letter article.
  FREE to everyone
  FREE to subscribers
Issue is available online to Treatment Guidelines subscribers signed up for online privileges.
 Issue is free to institutional users.
  $12.00
Non-subscribers may order copies of this issue of Treatment Guidelines and receive by postal mail or electronic download.
WANT TO SUBSCRIBE?
Subscribing online to The Medical Letter or Treatment Guidelines gives you the following privileges:
Access to the current issue of The Medical Letter or Treatment Guidelines (two separate subscriptions) on the day it is published.
Access to all articles published by The Medical Letter since 1988 or to Treatment Guidelines since its inception (September 2002).
As a subscriber to The Medical Letter or Treatment Guidelines, you will also receive your copy of the current issue by postal mail.
   
Individual Subscriptions - Individual print and online access, including access to a limited section of the searchable archives.  Shared access not allowed.
Individual Librarian Subscriptions - Print and online access for the head librarian only. It allows the librarian to conduct searches and provide data. Shared access not allowed. 
Group Site License - Preview Site License.  Print and online access for multiple users at multiple locations including access to the entire searchable archives. Please e-mail us for further information regarding The Medical Letter's pricing platform for site licenses.
 
 
 

 

 

 

 

 

 

 
© 2009 The Medical Letter. All rights reserved. Use of this site signifies your agreement to the Terms and Conditions.